Inflammation – III

Inflammation – III

Chemical Mediators of Inflammation – Sources, Actions and Functions

1

Chemical Mediators of Inflammation

Chemical mediators are substances released from cells or derived from plasma proteins that initiate and regulate the inflammatory response.

They are responsible for producing important changes during inflammation, such as vasodilation, increased vascular permeability, leukocyte recruitment, pain and fever.

Sources of Chemical Mediators

Cell-Derived

  • Tissue macrophages.
  • Mast cells.
  • Endothelial cells.
  • Leukocytes.
  • Platelets.

Plasma-Derived

  • Complement system.
  • Kinin system.
  • Coagulation system.

These mediators are mainly synthesized in the liver and circulate in inactive forms.

Classification of Cell-Derived Mediators

Preformed Mediators

  • Vasoactive amines: Histamine and serotonin.
  • Lysosomal enzymes: Enzymes stored in leukocyte granules.

Newly Synthesized Mediators

  • Arachidonic acid metabolites.
  • Platelet-activating factor (PAF).
  • Cytokines and chemokines.
  • Nitric oxide.
  • Free radicals.

Main Groups of Chemical Mediators

Vasoactive amines Histamine and serotonin.
Plasma protein systems Coagulation factors, kinins and complement.
Lipid mediators Prostaglandins, leukotrienes, lipoxins and PAF.
Cytokines and chemokines TNF, IL-1, IL-6 and IL-8.

General Properties

  • Most mediators act by binding to specific receptors on target cells.
  • Some act directly through enzymatic or toxic activity, such as lysosomal proteases.
  • They may stimulate target cells to produce secondary mediators, amplifying or controlling inflammation.
  • Their activity is tightly regulated by stimulators and inhibitors.
  • Many mediators can cause tissue damage if their effects are not controlled.
Important: Chemical mediators are essential for inflammation, but excessive or uncontrolled mediator activity can damage normal tissues.
2

Vasoactive Amines

Vasoactive amines are preformed mediators stored in cells. They mainly act on blood vessels and influence vascular permeability.

A. Histamine

Sources: Mast cells, basophils and platelets.

Histamine is stored in granules and released by a process called degranulation. It acts mainly by binding to H1 receptors on endothelial cells.

Actions of Histamine

  • Causes dilation of arterioles.
  • Increases vascular permeability, particularly in venules.
  • Allows fluid to escape into surrounding tissues, producing edema.
  • Produces a transient vascular response, generally lasting about 10–15 minutes.
Most important point: Histamine is the principal mediator of the immediate transient phase of increased vascular permeability.

Stimuli for Histamine Release

  • Physical stimuli.
  • Immune reactions.
  • Complement components.
  • Cytokines.
  • Products released by white blood cells.

Histaminase helps in the breakdown of histamine.

B. Serotonin (5-Hydroxytryptamine)

Sources: Platelets, enterochromaffin cells of the gastrointestinal tract and mast cells.
  • Serotonin is a preformed vasoactive mediator.
  • Its effects are similar to histamine but are less potent.
  • It is released during platelet aggregation.
  • Platelet aggregation may occur following contact with collagen, thrombin, ADP and antigen-antibody complexes.
Remember: Histamine and serotonin are both vasoactive amines. Histamine is particularly important in the immediate increase in vascular permeability.
3

Plasma Protein-Derived Mediators

Plasma protein-derived mediators are mainly synthesized in the liver. They circulate in inactive forms and become activated through enzyme cascades during inflammation.

Coagulation system Responsible for clot formation and related inflammatory effects.
Kinin system Produces bradykinin, which causes pain and vascular changes.
Complement system Helps in inflammation, phagocytosis and destruction of microbes.
Hageman factor Activation of Factor XII connects several plasma mediator pathways.

A. Coagulation System

Activation of Hageman factor (Factor XII) initiates the coagulation pathway. Thrombin is an important enzyme formed during this process.

Actions of Thrombin

  • Converts fibrinogen into fibrin, forming a blood clot.
  • Directly activates endothelial cells.
  • Acts on platelets and endothelial cells through protease-activated receptors.
  • Promotes leukocyte adhesion.
  • Produces fibrinopeptides that increase vascular permeability and attract leukocytes.
Fibrinogen
↓
Thrombin
↓
Fibrin formation
↓
Clot formation

B. Fibrinolytic System

The fibrinolytic system helps break down fibrin and remove the clot. Its important enzyme is plasmin.

Actions of Plasmin

  • Degrades fibrin and produces fibrin degradation products.
  • Can cleave complement C3 into C3a and C3b.
  • Activates Factor XII.
  • Contributes to vascular permeability and leukocyte migration.
  • Helps in clot lysis.

C. Kinin System

The kinin system produces bradykinin from kininogen through the action of kallikrein.

Factor XIIa
↓
Prekallikrein → Kallikrein
↓
High-molecular-weight kininogen
↓
Bradykinin

Actions of Bradykinin

  • Increases vascular permeability.
  • Causes arteriolar vasodilation.
  • Produces contraction of bronchial smooth muscle.
  • Causes pain.
Important: Bradykinin is short-lived and is rapidly broken down by enzymes called kininases.
4

Complement System

The complement system is a group of plasma proteins that play an important role in immunity and inflammation. Its components circulate in inactive forms and become activated through a cascade reaction.

Complement components are numbered C1 to C9. Activation of C3 is a critical step in the complement cascade.

Pathways of Complement Activation

Classical Pathway

Activated when C1 binds to antigen-antibody complexes.

Lectin Pathway

Activated through mannose-binding protein.

Alternative Pathway

Triggered by bacterial surfaces.

Functions of Complement in Acute Inflammation

1. Vascular Effects

C3a, C5a and C4a stimulate mast cells to release histamine. They are called anaphylatoxins because their effects resemble those of mast cell mediators in anaphylaxis.

  • Increase vascular permeability.
  • Promote vasodilation through histamine release.

2. Leukocyte Adhesion and Chemotaxis

C5a is a powerful chemotactic agent. It attracts and activates:

  • Neutrophils.
  • Monocytes.
  • Eosinophils.
  • Basophils.

3. Opsonization and Phagocytosis

C3b and C3bi attach to microbial surfaces and act as opsonins. This makes microbes easier for neutrophils and macrophages to recognize and engulf.

4. Cell Lysis

Complement components C5 to C9 form the membrane attack complex (MAC).

MAC creates pore-like openings in microbial membranes, causing damage and lysis of the invading microbes.

Regulation of Complement

Complement activation is tightly controlled by regulatory proteins to prevent damage to normal host cells.

  • Decay-accelerating factor (DAF): Helps regulate C3 and C5 convertases.
  • Factor I: Cleaves C3b.
  • C1 inhibitor: Regulates activation of the classical pathway.
  • CD59: Inhibits formation of the membrane attack complex.
High-yield points:
  • C3a and C5a – anaphylatoxins.
  • C5a – powerful chemotactic agent.
  • C3b and C3bi – opsonization.
  • C5–C9 – membrane attack complex.
5

Lipid Mediators

Lipid mediators are produced mainly by leukocytes, mast cells and endothelial cells. They can influence almost every step of inflammation.

They act rapidly and are short-lived because they are either spontaneously degraded or destroyed by enzymes.

A. Eicosanoids

Eicosanoids are inflammatory mediators derived from arachidonic acid. Important groups include prostaglandins, leukotrienes and lipoxins.

Prostaglandins

Prostacyclin (PGI₂)

  • Causes vasodilation.
  • Inhibits platelet aggregation.

Thromboxane (TXA₂)

  • Causes vasoconstriction.
  • Promotes platelet aggregation.
PGD₂, PGE₂ and PGF₂α: These prostaglandins contribute to vasodilation and edema.

Leukotrienes

Leukotrienes are arachidonic acid metabolites involved in inflammatory reactions. They are included among the important lipid mediators of inflammation.

Lipoxins

Lipoxins are lipid mediators that mainly act as inhibitors of inflammation and help limit the inflammatory response.
  • Activated platelets are an important source of lipoxins.
  • They are synthesized through transcellular pathways involving different cell types.
  • Platelets alone cannot form LXA₄ and LXB₄; they require leukocyte-derived intermediates.
  • They inhibit neutrophil chemotaxis and adhesion.
  • They stimulate monocyte adhesion.
  • They act as natural endogenous antagonists of leukotriene actions.
Remember: Lipoxins help control inflammation, particularly by limiting neutrophil recruitment and activity.

B. Platelet-Activating Factor (PAF)

PAF is a modified phospholipid generated from membrane phospholipids. It acts directly on target cells through a specific G-protein-coupled receptor.

Sources: Neutrophils, monocytes, platelets and endothelial cells.

Actions of PAF

  • Stimulates platelet activation.
  • Causes vasoconstriction and bronchoconstriction.
  • Can produce vasodilation and increased vascular permeability.
  • Promotes leukocyte aggregation, adhesion and chemotaxis.
  • Stimulates leukocyte degranulation and oxidative burst.
  • Promotes release of eicosanoids, including leukotrienes.
Important: PAF is a powerful inflammatory mediator. The presentation describes its effect on vascular permeability as much greater than that of histamine.
6

Cytokines and Chemokines

Cytokines are small polypeptides produced by many types of cells during immune reactions and inflammation. They help cells communicate and coordinate the inflammatory response.

Activated lymphocytes and macrophages are important sources of cytokines. Their secretion is generally transient and tightly regulated.

Modes of Cytokine Action

Autocrine

Acts on the same cell that releases the cytokine.

Paracrine

Acts on nearby cells.

Endocrine

Acts on distant cells or organs through the circulation.

Major Classes of Cytokines

  • Lymphocyte-regulating cytokines: IL-2 stimulates lymphocyte proliferation.
  • Innate immunity cytokines: TNF and IL-1.
  • Cell-mediated immunity cytokines: Interferons and IL-12.
  • Chemokines: Attract different types of leukocytes.
  • Hematopoiesis-stimulating cytokines: IL-3.

TNF and Interleukin-1 (IL-1)

Sources: Activated macrophages, mast cells and endothelial cells.

Local Effects

  • Activate endothelial cells and increase expression of adhesion molecules.
  • Stimulate production of other cytokines and chemokines.
  • Promote production of growth factors, eicosanoids and nitric oxide.
  • Increase thrombogenicity of the endothelium.
  • Promote aggregation and priming of neutrophils.
  • Activate fibroblasts, causing proliferation and increased extracellular matrix production.
  • Promote release of proteolytic enzymes that may contribute to tissue damage.

Systemic Effects

TNF and IL-1 can produce several systemic manifestations:
  • Fever.
  • Anorexia and lethargy.
  • Cachexia.
  • Leukocytosis.
  • Hypotension.
  • Acute-phase response.

Acute-Phase Proteins

TNF and IL-1 stimulate the liver to produce acute-phase proteins, including:

  • Complement components.
  • Coagulation factors.
  • Mannose-binding protein (mannan-binding lectin).
Important: TNF and IL-1 are major cytokines involved in acute inflammation. They produce both local inflammatory changes and systemic effects.
7

Lysosomal Enzymes of Leukocytes

Neutrophils and monocytes contain granules filled with enzymes and antimicrobial substances. These granules help destroy microorganisms but can also cause tissue injury.

How are Lysosomal Enzymes Released?

  • After leukocyte death.
  • By leakage during phagolysosome formation.
  • During unsuccessful or futile attempts at phagocytosis.

Types of Lysosomal Granules

Primary Granules

  • Myeloperoxidase.
  • Bactericidal factors.
  • Acid hydrolases.
  • Neutral proteases.
  • Elastase.
  • Collagenases.
  • Proteinase 3.

Secondary Granules

  • Lysozyme.
  • Collagenase.
  • Gelatinase.
  • Plasminogen activator.
  • Histaminase.
  • Alkaline phosphatase.

Types of Proteases

Acid Proteases

Act in the acidic environment of the phagolysosome.

Neutral Proteases

Include elastase, collagenase and cathepsin. They can damage extracellular matrix components and stimulate the complement cascade.

Effects of Lysosomal Enzymes

  • Increase vascular permeability.
  • Contribute to chemotaxis.
  • Cause tissue damage.

Control of Lysosomal Enzymes

Serum and tissue fluids contain antiproteases that limit enzyme activity and prevent excessive tissue destruction.

Important antiproteases:
  • α₁-antitrypsin.
  • α₂-macroglobulin.
Deficiency of these inhibitors can lead to uncontrolled tissue destruction.
8

Mediators and Their Effects – Quick Revision

Different chemical mediators are responsible for different inflammatory reactions. Some mediators have more than one action.

Vasodilation

Prostaglandins, nitric oxide and histamine.

Increased Vascular Permeability

Histamine, serotonin, C3a, C5a, bradykinin, leukotrienes and PAF.

Leukocyte Recruitment and Activation

TNF, IL-1, chemokines, C5a and leukotrienes.

Fever

IL-1, TNF and prostaglandins.

Pain

Prostaglandins, bradykinin and neuropeptides.

Tissue Damage

Lysosomal enzymes, nitric oxide and reactive oxygen radicals.